The seasonality of new‐onset refractory status epilepticus ( NORSE )
Epilepsia · 2023
DOI: 10.1111/epi.17606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Margaret T Gopaul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department. of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Encephalitis, Status Epilepticus, Drug Resistant Epilepsy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Philippe Foundation.
Abstract (Originalsprache)
The etiology of new‐onset refractory status epilepticus (NORSE), including its subtype with prior fever known as FIRES (febrile infection‐related epilepsy syndrome), remains uncertain. Several arguments suggest that NORSE is a disorder of immunity, likely post‐infectious. Consequently, seasonal occurrence might be anticipated. Herein we investigated if seasonality is a notable factor regarding NORSE presentation. We combined four different data sets with a total of 342 cases, all from the northern hemisphere, and 62% adults. The incidence of NORSE cases differed between seasons ( p = .0068) and was highest in the summer (32.2%) ( p = .0022) and lowest in the spring (19.0%, p = .010). Although both FIRES and non‐FIRES cases occurred most commonly during the summer, there was a trend toward FIRES cases being more likely to occur in the winter than non‐FIRES cases (OR 1.62, p = .071). The seasonality of NORSE cases differed according to the etiology ( p = .024). NORSE cases eventually associated with autoimmune/paraneoplastic encephalitis occurred most frequently in the summer ( p = .032) and least frequently in the winter ( p = .047), whereas there was no seasonality for cryptogenic cases. This study suggests that NORSE overall and NORSE related to autoimmune/paraneoplastic encephalitis are more common in the summer, but that there is no definite seasonality in cryptogenic cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department. of Neurology, Comprehensive Epilepsy Center, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
- AP-HP, Hôpital de la Pitié-Salpêtrière, DMU Neurosciences 6, Epilepsy Unit and Dept. of Clinical Neurophysiology, Paris, France.
- Universidad Autonoma de Centro America, School of Medicine, San Jose, Costa Rica.
- Nebraska Medical Center, Omaha, Nebraska, USA.
ORCID-Profile: Aurélie Hanin, Teneille E Gofton, Nicolas Gaspard, Lawrence J Hirsch
Förderung
- Philippe Foundation
Zitieren
APA
Gopaul, M. T., Hanin, A., Cespedes, J., Pulluru, Y., Kazazian, K., van Baalen, A., Gofton, T. E., Gaspard, N., & Hirsch, L. J. (2023). The seasonality of new‐onset refractory status epilepticus ( NORSE ). Epilepsia. https://doi.org/10.1111/epi.17606
Vancouver
Gopaul MT, Hanin A, Cespedes J, Pulluru Y, Kazazian K, van Baalen A, et al. The seasonality of new‐onset refractory status epilepticus ( NORSE ). Epilepsia. 2023. doi:10.1111/epi.17606
BibTeX
@article{Gopaul2023,
author = {Gopaul, Margaret T and Hanin, Aurélie and Cespedes, Jorge and Pulluru, Yashwanth and Kazazian, Karnig and van Baalen, Andreas and Gofton, Teneille E and Gaspard, Nicolas and Hirsch, Lawrence J},
title = {The seasonality of new‐onset refractory status epilepticus ( NORSE )},
journal = {Epilepsia},
year = {2023},
doi = {10.1111/epi.17606}
}
EUVIMED